{
    "Trade/Device Name(s)": [
        "Clearblue\u00ae Early Digital Pregnancy Test"
    ],
    "Submitter Information": "SPD Swiss Precision Diagnostics GmbH",
    "510(k) Number": "K200913",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123567"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "November 4, 2020",
    "Summary Letter Received Date": "November 6, 2020",
    "Submission Date": "August 11, 2021",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (hCG) test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine collection container"
    ],
    "Instrument(s)/Platform(s)": [
        "Clearblue Early Digital Pregnancy Test device"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic sandwich assay",
        "Lateral flow assay",
        "Digital result display"
    ],
    "Methodologies": [
        "Qualitative immunoassay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for Clearblue Early Digital Pregnancy Test\u2014an OTC lateral flow digital immunoassay for qualitative detection of hCG in urine to aid in early pregnancy detection",
    "Indications for Use Summary": "Over-the-counter chromatographic immunoassay for qualitative detection of hCG in urine to aid in early detection of pregnancy, usable as early as six days before missed period; intended for home use",
    "fda_folder": "Clinical Chemistry"
}